Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in AL Amyloidosis

NEXT STORY
Ayala Pharmaceuticals to Host Virtual KOL Event Reviewing Interim Data Presented at ESMO 2020 from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma
PREV STORY
Home Infusion Therapy Market to Exhibit 2.2% CAGR and Reach USD 86.89 Billion by 2027; Rising Prevalence of COVID19 Pandemic to Promote Growth, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Protech Home Medical Announces Date and Time for Q3 2020 Conference Call and Audio Webcast

author_avatar
NASDAQ Market News

In-vitro Diagnostics (IVD) Reagents Market Worth $77.6 billion by 2027, Growing at a CAGR of 7% From 2020, Says Meticulous Research®

author_avatar
NASDAQ Market News

Notice of Annual General Meeting in Immunicum AB (publ)

author_avatar
NASDAQ Market News